Apexigen Inc. (APGN)
NASDAQ: APGN
· Real-Time Price · USD
0.39
0.04 (9.86%)
At close: Aug 22, 2023, 9:59 PM
Apexigen Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 9.37M | 12.73M | 14.8M | 12.71M | 76.97M | 17.55M | 23.44M | 274.49K | 352.13K | 421.02K |
Short-Term Investments | n/a | n/a | 2M | 7.96M | 51.7M | 10.39M | 12.92M | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 58.08M | 58.08M | 58.08M |
Other Long-Term Assets | 483K | 947K | 1.41M | 2.21M | 51.7B | 331K | 327K | n/a | n/a | n/a |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 286K | 426K | 2.62M | 4.32M | 43.05M | 2.57M | 1.68M | 67.63K | 121.84K | 186.24K |
Total Current Assets | 12.6M | 16.63M | 21.19M | 24.99M | 120.02M | 30.51M | 38.04M | 342.12K | 473.97K | 607.26K |
Property-Plant & Equipment | n/a | n/a | 250K | 374K | n/a | 606K | 728K | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 483K | 947K | 1.66M | 2.58M | 51.7B | 937K | 1.05M | 58.08M | 58.08M | 58.08M |
Total Assets | 13.08M | 17.58M | 22.86M | 27.57M | 51.82B | 31.44M | 39.1M | 58.42M | 58.55M | 58.68M |
Account Payables | 3.38M | 2.81M | 5.34M | 3.34M | 132.99M | 4.68M | 4.49M | 30.29K | 26.81K | 7.03K |
Deferred Revenue | 6.66M | 6.15M | 5.66M | 5.14M | n/a | 4.12M | 3.61M | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | 106K | 210K | 862.76M | 378K | 369K | n/a | n/a | n/a |
Other Current Liabilities | 5.36M | 5.49M | 5.36M | 8.45M | 3.82B | 8.8M | 8.49M | 116.73K | 86.06K | 75.61K |
Total Current Liabilities | 15.4M | 14.45M | 16.47M | 17.13M | 4.82B | 17.98M | 16.95M | 147.02K | 112.87K | 82.64K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | 35K | 141K | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | 10K | 11K | 28K | 14.09M | 158.71M | 158.71M | 86.34K | 328.52K | 208.72K |
Total Long-Term Liabilities | n/a | 10K | 11K | 28K | 14.09M | 158.74M | 158.85M | 86.34K | 328.52K | 208.72K |
Total Liabilities | 15.4M | 14.46M | 16.48M | 17.16M | 4.83B | 176.72M | 175.8M | 233.36K | 441.39K | 291.36K |
Total Debt | n/a | n/a | 106K | 210K | 862.76M | 413K | 510K | n/a | n/a | n/a |
Common Stock | 2K | 2K | 2K | 2K | 51.62B | 31K | 31K | 58.08M | 53.11M | 53.39M |
Retained Earnings | -188.89M | -182.85M | -176.79M | -170.36M | -4.63B | -153.77M | -144.72M | -378.04K | -453.41K | -171.83K |
Comprehensive Income | n/a | n/a | n/a | -5K | n/a | -2K | -4K | n/a | n/a | n/a |
Shareholders Equity | -2.32M | 3.11M | 6.38M | 10.41M | 46.99B | -145.28M | -136.71M | 58.19M | 58.11M | 5M |
Total Investments | n/a | n/a | 2M | 7.96M | 51.7M | 10.39M | 12.92M | 58.08M | 58.08M | 58.08M |